Your browser doesn't support javascript.
loading
Blood neurofilament light as a potential endpoint in Phase 2 studies in MS.
Sormani, Maria Pia; Haering, Dieter A; Kropshofer, Harald; Leppert, David; Kundu, Uma; Barro, Christian; Kappos, Ludwig; Tomic, Davorka; Kuhle, Jens.
Afiliação
  • Sormani MP; Department of Health Sciences (DISSAL) University of Genova Genova Italy.
  • Haering DA; Novartis Pharma AG Basel Switzerland.
  • Kropshofer H; Novartis Pharma AG Basel Switzerland.
  • Leppert D; Novartis Pharma AG Basel Switzerland.
  • Kundu U; Novartis Healthcare Pvt. Ltd. Hyderabad India.
  • Barro C; Neurologic Clinic and Policlinic, Departments of Medicine, Clinical Research, Biomedicine and Biomedical Engineering University Hospital Basel, University of Basel Basel Switzerland.
  • Kappos L; Neurologic Clinic and Policlinic, Departments of Medicine, Clinical Research, Biomedicine and Biomedical Engineering University Hospital Basel, University of Basel Basel Switzerland.
  • Tomic D; Novartis Pharma AG Basel Switzerland.
  • Kuhle J; Neurologic Clinic and Policlinic, Departments of Medicine, Clinical Research, Biomedicine and Biomedical Engineering University Hospital Basel, University of Basel Basel Switzerland.
Ann Clin Transl Neurol ; 6(6): 1081-1089, 2019 Jun.
Article em En | MEDLINE | ID: mdl-31211172

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas de Neurofilamentos / Esclerose Múltipla Recidivante-Remitente Tipo de estudo: Clinical_trials Limite: Adult / Humans / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas de Neurofilamentos / Esclerose Múltipla Recidivante-Remitente Tipo de estudo: Clinical_trials Limite: Adult / Humans / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article